Articles By Rob Wright
Life Science Connect Chief Editors Get Rare Behind Scenes Tour Of Lilly Research Labs
Life Science Leader magazine’s chief editor Rob Wright, and Outsourced Pharma and Clinical Leader chief editor Ed Miseta (part of the Life Science Connect group of publications), were recently granted a rare behind the scenes tour of three of Eli Lilly (NYSE: LLY) Research Laboratories (LRL) at the company’s global corporate headquarter in Indianapolis on October 2, 2013.
Drug Take-Back Programs – Coming To A Municipality Near You
While some believe self-funded regulatory agencies to be a good thing, others feel it allows industry to have major leverage over FDA policy decision making.
Private Or Public? Not Really Even A Question In Life Sciences?
When launching a start-up in the life sciences industry the question of going public or private could be a struggle. A key driver for the decision to go public is the availability of funding sources and management’s experiences and relationships, says Punit Dhillon, president and CEO of OncoSec Medical Inc.
Can India Achieve cGMP For Vaccines? Does It Matter?
Bharat Biotech pledged to sell Rotovac for the rotavirus for $1 a dose to compete with GSK and Merck, if they make it cheaper can they make it safer?
MedImmune’s Blueprint For Building A Biologics R&D Engine
Bahija Jallal, VP of translational science for MedImmune, has some insights on how to successfully focus your biologics R&D operation to encourage, not kill the entrepreneurial spirit on which it was built.
Can Pharma And Biotech Companies Trust Emerging Markets To Protect IP?
How long can or should biotech and pharmaceutical companies continue to conduct business in regions where there is government-enabled IP theft?
Africa – The Next Frontier For Novartis Clinical Development
Novartis accelerated year-over-year in the emerging market of Sub-Saharan Africa by developing the Region Group Emerging Market (GEM).
How To Create An Innovative Culture In A Pharma Company
Endo Pharmaceuticals explains what it takes to boost an innovative culture for a pharma company. By Rob Wright
GSK’s Seekers Of Disruptive Innovation
John Baldoni, SVP PTS within GSK, created The Seekers, an idea generation team to stimulate disruptive innovation and serve as a catalyst for creating tipping points sooner. By Rob Wright